START is a clinical research site located in San Antonio, Texas, United States 78229.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
START has participated in 13 clinical trials with 5 currently active.
Therapeutic areas: Advanced or Metastatic Solid Tumors, Carcinoma, Metastatic Cancer.
Sponsors: Hoffmann-La Roche, Spectrum Pharmaceuticals, Inc, Incyte Corporation.
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
START has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
START has 13 clinical trials on record, with 5 currently active. Their work covers Advanced or Metastatic Solid Tumors, Carcinoma, Metastatic Cancer.
Yes — START holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.